Zhongzhi Pharmaceutical Holdings Limited (ZHONGZHIPHARM) announced that its 2025 Annual Report, a shareholder circular dated 21 April 2026 and the related form of proxy have been uploaded to both the company website (www.zeus.cn) and the HKEXnews portal (www.hkexnews.hk).
The circular outlines four key agenda items for the forthcoming annual general meeting (AGM): 1. Granting of general mandates to repurchase and issue shares. 2. Re-election of directors. 3. Proposed amendments to, and adoption of, the amended and restated Memorandum and Articles of Association. 4. Formal notice of the AGM.
The AGM is scheduled for 13 May 2026. Shareholders may submit their votes through the accompanying form of proxy.
Registered shareholders can opt to receive future corporate-communication alerts via email by completing and returning the reply form included in the mailing. For those who experience difficulty accessing online documents, printed copies will be provided free of charge upon request.
Enquiries regarding share registration matters can be directed to Union Registrars Limited at +852 2849 3399 during business hours.